Edit |   |
---|---|
Antigenic Specificity | CD221, Human (Teprotumumab biosimilar) |
Clone | Teprotumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD221 Recombinant Antibody (Teprotumumab). Teprotumumab, sold under the brand name Tepezza, is a medication used to treat adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to bulge outwards. |
Immunogen | n/a |
Other Names | Anti-CD221 Recombinant Antibody, Research Grade Teprotumumab, Anti-Human CD221 Recombinant Antibody(Teprotumumab), RO4858696-000, Antibody Drug Analogues, Monoclonal Antibody, YR1228, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1036734-93-6 |
Catalog # | YR1228 |
Price | please inquire |
Order / More Info | CD221, Human (Teprotumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |